Rossari Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

11.03

11.01

10.39

10.15

4.40

Share application money

-

3.29

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

847.67

770.23

394.06

273.32

120.08

Loan funds

Secured loans

64.92

-

-

61.01

5.80

Unsecured loans

-

-

-

-

-

Total

923.61

784.52

404.44

344.49

130.28

Uses of funds

Fixed assets

Gross block

247.35

245.92

216.53

119.97

132.50

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

91.92

68.55

45.78

26.43

50.90

Net block

155.44

177.38

170.75

93.54

81.59

Capital work-in-progress

13.68

0.84

0.32

21.75

2.83

Investments

493.09

380.86

9.25

15.21

0.20

Net current assets

Current assets, loans & advances

463.47

366.86

364.03

337.79

165.74

Less : current liabilities & provisions

202.06

141.41

139.92

123.80

120.08

Total net current assets

261.41

225.45

224.12

213.99

45.66

Miscellaneous expenses not written

-

-

-

-

-

Total

923.61

784.52

404.44

344.49

130.28

Notes:

Book value of unquoted investments

472.78

380.86

9.25

4.65

0.20

Market value of quoted investments

20.31

9.01

-

10.56

-

Contingent liabilities

125.56

178.26

5.13

21.23

-

Number of equity sharesoutstanding (Lacs)

551.55

550.56

519.29

507.53

44.00